Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
Cyclacel Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Cyclacel Pharmaceuticals reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Cyclacel Pharmaceuticals received on average a compensation package of $947K, a 6% increase compared to previous year.
Average pay of disclosed executives at Cyclacel Pharmaceuticals
Spiro Rombotis, Chief Executive Officer, received $1.3M in total, which decreased by 5% compared to 2020. 40% of Rombotis' compensation, or $531K, was in salary. Rombotis also received $265K in bonus, $500K in option awards, as well as $44K in other compensation.
Mark Kirschbaum, Chief Medical Officer, received a compensation package of $795K, which increased by 75% compared to previous year. 44% of the compensation package, or $350K, was in salary.
Paul McBarron, Chief Financial Officer, earned $708K in 2021, a 15% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2022.